Anthony Venturino, Partner at Novak Druce + Quigg, LLP talks about the key issues of patents in the emerging markets and the importance of relationships when protecting IP rights




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Anthony Venturino, Partner at Novak Druce + Quigg, LLP talks about the key issues of patents in the emerging markets and the importance of relationships when protecting IP rights
Released on: July 20, 2011. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks to Anthony Venturino, Partner of Novak Druce + Quigg, LLP
Novak Druce + Quigg LLP: Focus and Practice
Fintan Walton:
Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London 2011. On this show I have Anthony P. Venturino, who is a Partner at a company called Novak Druce a Law Firm, welcome to the show.
Anthony P. Venturino:
Thank you.
Fintan Walton:
Tony, you are a patent lawyer could you tell us little bit about what your practice actually is?
Anthony P. Venturino:
It's mostly what they call patent prosecution and procurements or your writing and then after you write the case and file it trying get that thing allowed.
Fintan Walton:
Sure and does that involve patent strategies as well?
Anthony P. Venturino:
Yes, there is a lot of planning involved in where a company is going to go with, what kind of industries they want to get in to and then what kind of protection they want for those industries.
Fintan Walton:
And your advice is not just only for, obviously you are a US based firm, but your advice is international advice?
Anthony P. Venturino:
In general and if I get in over my head I contact somebody in the appropriate country.
Fintan Walton:
Wherever necessary?
Anthony P. Venturino:
Right.
Fintan Walton:
Okay, so your prosecution of patents includes obviously pharmaceuticals and biotechnology but you are outside that field as well?
Anthony P. Venturino:
Lot of chemistry and then a lot of miscellaneous things like today I will be working on motorcycle patent after the conference is finished.
Key issues related to emerging markets
Fintan Walton:
Wonderful. Now one of the panel discussions you are going to be involved in here at this conference is on the emerging markets?
Anthony P. Venturino:
Correct.
Fintan Walton:
And as a person who practices and has an extensive experience with patents and the ups and downs of trying to get patents through and so forth, when we look at the emerging markets and you are advising your clients what would you see as the key issues?
Anthony P. Venturino:
Well it's gonna be what kind of protection you can get, but lot depends on what your plan on doing in those markets, are you buying from them, are you selling to them, are you going to go in there with the partners or you going in there on your own and there will be different ways of looking at it, the common way of we are going in and you are trying to sell to the market either products or your technology sometimes takes a lot of patience.
Fintan Walton:
Sure and those markets are changing?
Anthony P. Venturino:
They are constantly evolving.
Fintan Walton:
And obviously from a commercial perspective but also some of these emerging markets have only recently adopted WTO standards and are now competent enough to be able to accept the patent process, but there is still untried to some extent.
Anthony P. Venturino:
That's right, yes.
Fintan Walton:
Does that make your advice different?
Anthony P. Venturino:
Well it will, because in some cases the patents are much more valuable than others interestingly enough some countries trademarks and copyrights are the most valuable thing.
Fintan Walton:
Sure, and sometimes people argue well it doesn't really matter if you have a patent in those particularly territories, because in the end it's your brand and your marketing collab that really matters exactly?
Anthony P. Venturino:
That's were the trademarks and the copyrights come in right it's getting that name out very important.
Growth and strength of the Brazilian economy
Fintan Walton:
Sure, and your own experiences with Brazil, how do you see Brazil evolving now from your clients perspective is this really one of the key strongest economies and is this the right time to get into Brazil?
Anthony P. Venturino:
Yes it's a great economy, it's growing, growing middle class and I'd say especially if you are in chemicals kind of an area or service, oil service company it's phenomenal time to get involved.
Fintan Walton:
Sure, and one of the important things of course is when you do a deal in those territories with other local companies if they have a share in the intellectual property rights in some form does that make the task lot easier?
Anthony P. Venturino:
Typically, typically it's good to have that local partner.
Anthony's perspective: World economy and future issues to be resolved in patent protection
Fintan Walton:
Sure, and when you look at as a patent lawyer looking into the future and seeing the world economy evolve, what do you think are still the key issues that need to be resolved?
Anthony P. Venturino:
Well in some places stability in fact of the local government whatever that might be. I think respect for the IP rights or realization that there is such a thing in something in the more really undeveloped areas a lot of it right now is very much personal relationships and the IP rights are as good as you your connections unfortunately but that's another thing has really developed personal or relationships almost anywhere you go, because they are always gonna come in very valuable.
Fintan Walton:
And then there really historically the way in which you actually protect your position within a particular territory is still relationships rather than true traditional patents and the copyright?
Anthony P. Venturino:
It really can be and if it's not a direct one on one relationship it's that may be your new partner knows just how to do things in that country.
Fintan Walton:
Anthony P. Venturino, thank you very much indeed for coming on the show.
Anthony P. Venturino:
You are welcome.
Fintan Walton
Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).
Anthony P Venturino
Partner
Anthony P. Venturino currently serves as Partner at Novak Druce + Quigg LLP. Anthony P. Venturino has prepared numerous U.S. and PCT patent applications, trademark applications and opinions, and participated in major litigations. He has also been responsible for a number of complex activities including negotiating and drafting agreements, conducting due diligence for multi-million dollar technology acquisitions, and counseling senior management on intellectual property issues. Anthony P. Venturino has corporate and law firm experience as a chemical engineer with Exxon, is a licensed professional engineer in New Jersey, and was also a patent counsel with U.S. Surgical Corporation. His fields of technical expertise include chemistry, catalysts, oil, gas and coal processing, metallurgy, surfactants, polymers, pharmaceuticals, compositions, biotechnology, and medical devices. He has lectured extensively on U.S. patent practice both in the United States and abroad. He is ranked as "AV" from Martindale Hubbell Law Directory, the highest rating given to participating attorneys. Over the years, Anthony P. Venturino has been recognized by his peers as a top lawyer in his field.
PharmaVentures
PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.
Novak Druce + Quigg LLP
Novak Druce + Quigg LLP is a national law firm focused exclusively on complex intellectual property matters. With a renowned reexamination practice and over 80 attorneys and professionals in offices in Houston, TX, San Francisco, CA, Washington, DC and West Palm Beach, FL, Novak Druce attorneys help clients navigate the complexities of U.S. intellectual property law by securing, enforcing, and defending their intellectual property rights. The Novak Druce Centre for Professional Service Firms at the University of Oxford's Said Business School launched in October 2009. The Centre explores key challenges confronting the professional services sector, conducts research and provides training to further the advancement of the management of professional service firms.